Every fall, millions of people line up for flu shots, COVID boosters, and whatever else the season demands. Each vaccine targets one specific threat. Miss a variant, and you are exposed. Skip a year, and your protection fades. For 230 years, that has been the deal: one vaccine, one pathogen. But a team of Stanford Medicine researchers just threw that entire model out the window. They created a vaccine formula that protected mice against coronaviruses, bacterial infections, and even household allergens, all with a simple drop in the nose. No needles. No pathogen-specific ingredients. No precedent in the history of immunology. The researchers themselves did not expect it to work this well. And if it translates to humans, it could replace an entire medicine cabinet of annual shots with a single nasal spray.
230 Years of Vaccines, One Basic Principle
To understand why this study matters, you need to know how every vaccine in existence works. Since Edward Jenner rubbed cowpox on a boy’s arm in the 1790s and coined the term “vaccination,” every vaccine developed since has relied on the same core idea: antigen specificity.
A vaccine shows your immune system a piece of a pathogen, a protein from its surface, a weakened version of the whole organism, or genetic instructions to build one of its components. Your adaptive immune system learns to recognize that specific piece. When the real pathogen shows up, your body already knows how to fight it.
This works well for stable viruses. Two doses of the MMR vaccine provide near-lifetime protection against measles, mumps, and rubella. But for viruses that mutate fast, like influenza and SARS-CoV-2, antigen-specific vaccines have a shelf life. Last year’s flu shot may not match this year’s dominant strain. Last year’s COVID booster may not cover the latest variant.
Bali Pulendran, professor of microbiology and immunology at Stanford and senior author of the new study, described the problem: like the proverbial leopard that changes its spots, a virus can change the antigens on its surface. For these pathogens, a fundamentally different approach is needed.
The Idea That Sounded “Outrageous”
Scientists have known for decades that some vaccines produce unexpected side benefits. The BCG vaccine, given to about 100 million newborns each year to protect against tuberculosis, has been linked to reduced infant mortality from other, unrelated infections. The oral polio vaccine has shown similar off-target protection.
These observations hinted that the immune system could be trained to fight broadly, not just specifically. But the mechanism was poorly understood, the effects were inconsistent, and nobody had been able to engineer a vaccine around this principle on purpose.
Pulendran admitted that the idea sounded outrageous. He said nobody was seriously entertaining that something like this could ever be possible. Most attempts at “universal” vaccines had far more modest goals: covering all strains within one virus family, like all flu viruses or all coronaviruses. A single formula that could handle viruses, bacteria, and allergens was considered science fiction.
The 2023 Breakthrough That Changed Everything
In 2023, Pulendran’s team published a study that cracked open the mystery of how the BCG vaccine produces its broad protection. The key was in how two branches of the immune system interact.
Your immune system has two main arms. The innate immune system responds within minutes to any perceived threat, deploying generalist cells like dendritic cells, neutrophils, and macrophages that attack anything foreign. It is fast but non-specific, and it usually fades within days.
The adaptive immune system takes longer to ramp up, sometimes two weeks, but produces highly targeted weapons: antibodies and T cells designed to recognize specific pathogens. Once trained, adaptive immune cells can remember their targets for years.
Every existing vaccine works through the adaptive system. You wait two weeks for full protection because that is how long the adaptive response takes to build up.
Pulendran’s 2023 study revealed something unexpected about the BCG vaccine. It activated both immune branches, as most vaccines do, but unusually, the innate response did not fade after a few days. T cells recruited to the lungs as part of the adaptive response were sending chemical signals (cytokines) to innate immune cells, telling them to stay active.
Those T cells kept the innate immune system running for months instead of days. As long as the innate response remained active, mice given the BCG vaccine were also protected against SARS-CoV-2, and other coronaviruses, pathogens the vaccine was never designed to fight.
The team identified the specific signals involved: cytokines that activate toll-like receptors on innate immune cells. Armed with that knowledge, they speculated that a synthetic vaccine could be engineered to reproduce the same effect.
Building a Vaccine From Scratch
Two and a half years later, the team delivered on that speculation. They created a formula called GLA-3M-052-LS+OVA that contains two key components.
First, molecules that mimic the T cell signals were identified in the 2023 study. These molecules bind to and activate toll-like receptors on innate immune cells, essentially flipping the switch that keeps the innate response running.
Second, a harmless antigen called ovalbumin (OVA), a protein found in eggs. In a traditional vaccine, the antigen would be a piece of the target pathogen. Here, ovalbumen serves a completely different purpose: it recruits T cells into the lungs, where they maintain the innate response for weeks to months by continuing to send activation signals.
The vaccine does not contain any piece of any pathogen. It does not teach the immune system to recognize a specific virus or bacterium. Instead, it creates a self-sustaining feedback loop between innate and adaptive immunity that keeps the lungs in a heightened state of readiness against anything that tries to enter.
Pulendran described it as a double whammy. The prolonged innate response provides broad, immediate defense. Any pathogens that slip through are met by an adaptive response that activates in as little as three days, compared to two weeks in unvaccinated animals.
What Happened When They Tested It
The vaccine was delivered as a nasal drop to groups of mice. Some received up to four doses, spaced one week apart. After allowing the vaccine to take effect, researchers exposed each group to a different respiratory threat.
Against viruses: Three doses protected mice against SARS-CoV-2 and other coronaviruses, including ones that cause the common cold, for at least three months. Unvaccinated mice suffered dramatic weight loss, lung inflammation, and often died. Vaccinated mice lost far less weight, all survived, and their lungs were nearly clear of virus. Viral levels in vaccinated lungs dropped 700-fold compared to unvaccinated animals.
Against bacteria: The team then tested two bacterial pathogens: Staphylococcus aureus and Acinetobacter baumannii, both common causes of hospital-acquired infections. Vaccinated mice were protected against both for about three months.
Against allergens: Pushing further, researchers exposed mice to a protein from house dust mites, a common trigger for allergic asthma. Unvaccinated mice showed a strong allergic response and mucus buildup in their airways. Vaccinated mice showed no allergic reaction and maintained clear airways.
The vaccine suppressed the type of immune response (called Th2) that drives allergic reactions, suggesting it could have applications beyond infectious disease.
Why a Nasal Spray Changes the Game
Delivering the vaccine through the nose is not just about avoiding needles. It is strategically important because respiratory pathogens enter the body through the airways. By activating immune defenses directly in the lungs, the vaccine creates protection exactly where threats arrive first.
Traditional injected vaccines build systemic immunity in the blood, which eventually reaches the lungs but may not be as concentrated or as fast-acting at the point of entry. A nasal vaccine primes the lung’s local immune environment, creating a frontline defense that intercepts pathogens before they can establish infection.
A future human version could take the form of a simple nasal spray, administered in a doctor’s office or even at home. Pulendran believes two doses would likely be enough to protect humans.
Five to Seven Years From Your Medicine Cabinet
Translating animal findings to human medicine is a long, uncertain road. Pulendran estimated that with adequate funding, a universal respiratory vaccine for humans could be available in five to seven years, and that is the best-case scenario.
The next step is a Phase I safety trial in humans, followed by a larger trial where vaccinated people are exposed to infections under controlled conditions. Both stages carry the risk of failure, and many promising animal results do not survive the jump to human biology.
But if the results hold, the implications would be enormous. Pulendran painted the picture: imagine getting a nasal spray in the fall months that protects you from all respiratory viruses, including COVID-19, influenza, respiratory syncytial virus, and the common cold, as well as bacterial pneumonia and early spring allergens. That would transform medical practice.
No more choosing between a flu shot and a COVID booster. No more hoping this year’s formulation matches the circulating strains. No more scrambling when a novel pandemic virus appears. One spray, broad protection, several months of coverage.
Why This Is Different From Everything Before
What makes this vaccine fundamentally new is not just the breadth of protection. It is the mechanism. Every vaccine in history has trained the adaptive immune system to recognize a specific target. This one sustains the innate immune system, the branch that fights broadly but usually fades within days, for months at a time.
By creating a feedback loop in which adaptive T cells continuously signal innate cells to remain active, the researchers effectively merged two defense systems that normally operate on distinct timelines and scopes. The result is a vaccine that does not need to know what pathogen is coming. It just keeps the lungs armed and ready for anything.
The study was published in Science. Researchers from Emory University, the University of North Carolina at Chapel Hill, Utah State University, and the University of Arizona contributed. Funding came from the National Institutes of Health, the Violetta L. Horton Professor endowment, the Soffer Fund endowment, and Open Philanthropy.
My Personal RX on Strengthening Your Immune System Year-Round
Your immune system is your first and last line of defense against respiratory infections, allergens, and chronic disease. While a universal vaccine may still be years away, you can take daily steps to keep both your innate and adaptive immune systems functioning at their best. I tell my patients that immune health is not a seasonal project but a daily practice built on good nutrition, quality sleep, movement, and stress management. Here is what I recommend:
- Prioritize Deep, Restorative Sleep: Your immune system performs critical maintenance during deep sleep, producing cytokines and T cells that fight infection. Sleep Max combines magnesium, GABA, 5-HTP, and taurine to calm your mind, support neurotransmitter balance, and promote restorative REM sleep so your body can build and repair immune defenses each night.
- Know Which Supplements Your Immune System Needs After 40: Nutrient absorption declines with age, leaving gaps in immune function. Download my free guide, The 7 Supplements You Can’t Live Without, to learn which supplements strengthen your defenses, which “healthy” foods may be misleading you, and how to spot quality products.
- Exercise for at Least 30 Minutes Daily: Moderate physical activity increases circulation of immune cells, reduces inflammation, and improves the body’s ability to detect and respond to pathogens. Walking, cycling, swimming, and yoga all count.
- Get Your Annual Vaccines on Schedule: Until a universal vaccine exists, stay current with seasonal flu shots, COVID boosters, and any other recommended immunizations for your age group. Each one primes your adaptive immune system against specific circulating threats.
- Manage Chronic Stress: Prolonged stress raises cortisol, which suppresses both innate and adaptive immune responses. Practice daily breathwork, meditation, or time in nature to keep your stress hormones in check and your immune system responsive.
- Stay Hydrated: Your respiratory mucous membranes need adequate hydration to trap and expel pathogens. Aim for at least 8 glasses of water per day to keep your airways functioning as an effective first line of defense.
- Wash Your Hands and Improve Indoor Air Quality: Simple hygiene and clean air remain two of the most effective ways to prevent respiratory infections. Use air purifiers, open windows when possible, and wash hands frequently during cold and flu season.
- See Your Doctor at the First Sign of Persistent Respiratory Symptoms: Do not ignore a cough, congestion, or breathing difficulty that lingers beyond a week. Early evaluation helps catch infections and inflammatory conditions before they progress.
Source: Drew, L. (2026). βUniversal vaccineβ protects mice against multiple pathogens. Nature. https://doi.org/10.1038/d41586-026-00506-y
